• SGI-1027 and Everolimus Synergy: New Mechanisms in RCC Thera

  2026-04-22

  This study identifies the DNA methyltransferase inhibitor SGI-1027 as a methuosis inducer that synergizes with everolimus to promote apoptosis and pyroptosis in renal cell carcinoma (RCC). By elucidating the role of lysosomal membrane permeability and GSDME-dependent pyroptosis, the research suggests new avenues to overcome everolimus resistance in advanced RCC treatment.

• Deep Learning of Urine Stem Cell Mitochondria as AD Biomarke

  2026-04-21

  Yan et al. demonstrate a deep learning framework using live urine-derived stem cell (USC) mitochondrial morphology to non-invasively distinguish cognitive impairment in Alzheimer’s disease (AD). This approach offers a dynamic, accessible biomarker platform with strong translational potential for early AD detection.

• Coumestrol in RA: Mechanistic Advances for Translational Res

  2026-04-21

  This thought-leadership article explores Coumestrol (SKU C5832) as a next-generation phytoestrogen estrogen receptor antagonist for translational research, focusing on its emerging mechanistic roles in rheumatoid arthritis (RA) and nuclear receptor modulation. Blending mechanistic insight with strategic guidance, it highlights Coumestrol’s unique ability to induce ferroptosis in fibroblast-like synoviocytes, its selectivity as a SERM, and its translational potential. Practical protocol parameters, competitive positioning, and future outlook are provided to empower researchers aiming for both reproducibility and innovation.

• Angiotensin II: Mechanistic and Strategic Advances in Vascul

  2026-04-20

  This thought-leadership article explores the mechanistic underpinnings and translational strategies of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) in vascular biology. It provides actionable guidance for hypertension, cardiovascular remodeling, and abdominal aortic aneurysm (AAA) research, while integrating recent findings on the renin–angiotensin system's cross-domain relevance in antiviral studies. The piece distinguishes itself from typical product pages by offering deep mechanistic context, evidence-labeled protocol guidance, and a forward-looking view on translational research opportunities.

• Angiotensin II in Endothelial Dysfunction: Mechanisms and Re

  2026-04-20

  Explore how Angiotensin II serves as a critical tool for unraveling endothelial dysfunction and hypertension mechanisms. This in-depth article integrates advanced research protocols and unique assay guidance, providing practical insights for cardiovascular investigators.

• Macrophage EV miR-660 Drives Breast Cancer Metastasis via NF

  2026-04-19

  This study uncovers how tumor-associated macrophage-derived extracellular vesicles (EVs) transfer miR-660 to breast cancer cells, promoting metastasis by suppressing KLHL21 and activating the IKKβ/NF-κB p65 pathway. The findings clarify the mechanistic role of TAM-EV miRNAs in breast cancer progression and highlight novel regulatory axes for therapeutic exploration.

• Decoding Dual-Mode mRNA Tracking: EZ Cap™ Cy5 Firefly Lucife

  2026-04-18

  Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) advances real-time mRNA delivery and translation assays. This article uniquely connects dual-modality reporter capabilities to protocol optimization and practical assay design.

• Pemetrexed Disodium in Cancer Chemotherapy Research: Workflo

  2026-04-17

  Pemetrexed disodium empowers cancer researchers to dissect folate metabolism and nucleotide biosynthesis with precision, targeting multiple enzymes critical for DNA and RNA synthesis. This article highlights advanced experimental workflows, troubleshooting insights, and translational applications of pemetrexed—enabling robust, mechanism-driven studies in non-small cell lung carcinoma, malignant mesothelioma, and beyond.

• Vorinostat for Epigenetic Modulation: Applied Oncology Workf

  2026-04-16

  Vorinostat (SAHA, MK0683) offers precise, reproducible HDAC inhibition for apoptosis and epigenetic modulation in cancer biology. This guide translates new mechanistic insights into actionable workflows, troubleshooting, and protocol optimization for advanced oncology research.

• Targeted CRISPRi Delivery to Adipocytes Ameliorates Obesity

  2026-04-15

  This study introduces a targeted, nonviral CRISPR interference system that selectively silences Fabp4 in white adipocytes, leading to reduced obesity, inflammation, and hepatic steatosis in vivo. The approach demonstrates improved specificity and therapeutic efficacy over conventional anti-obesity strategies, with implications for metabolic and liver disease research.

• BMN 673 (Talazoparib): Selective, Potent PARP1/2 Inhibitor P

  2026-04-14

  BMN 673 (Talazoparib) is a highly potent and selective PARP1/2 inhibitor with sub-nanomolar activity and robust PARP-DNA complex trapping. It targets homologous recombination deficiency, showing superior cytotoxicity in BRCA2-mutant and DNA repair-deficient cells. This article details the biochemical rationale, mechanism, and evidence supporting its use in precision cancer research.

• HotStart 2X Green qPCR Master Mix: Precision in Gene Express

  2026-04-13

  HotStart™ 2X Green qPCR Master Mix enables high-fidelity gene expression analysis across challenging pluripotency models, with antibody-mediated hot-start control for reproducible quantification. Its streamlined protocol and robust specificity empower advanced applications like enhancer function studies and RNA-seq validation.

• Indomethacin Sodium Trihydrate: Pathway-Specific Insights fo

  2026-04-13

  Explore Indomethacin Sodium Trihydrate’s (Indometacin Sodium) distinct roles in inflammation, pain, and regenerative research. This article provides advanced, pathway-focused perspectives and actionable protocols, setting a new benchmark for sodium 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate application.

• CHIR 99021 Trihydrochloride: GSK-3 Inhibitor for Organoid Pr

  2026-04-12

  CHIR 99021 trihydrochloride empowers researchers to fine-tune stem cell self-renewal and differentiation in organoid models, enabling unprecedented scalability and cell-type diversity. This article details advanced protocols, troubleshooting strategies, and insights from the latest breakthroughs for next-level insulin signaling and metabolic research.

• APEX2 Regulates TERT Expression in Human Embryonic Stem Cell

  2026-04-12

  This study identifies APEX2 as a critical DNA repair enzyme required for efficient expression of TERT in human embryonic stem cells. By elucidating APEX2’s distinct gene regulatory role, the paper opens new avenues for understanding telomerase control in stem cell maintenance and cancer.

15834 records 1/1056 page Next 12345 下5页 Last page